| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
119 |
99 |
$0.00 |
| 3351F |
|
168 |
149 |
$0.00 |
| 96127 |
|
447 |
393 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
25 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
136 |
110 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
170 |
155 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
308 |
272 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
69 |
57 |
$0.00 |
| 87807 |
|
67 |
52 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
152 |
146 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,102 |
600 |
$0.00 |
| 3725F |
|
283 |
254 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
144 |
119 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
386 |
331 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
577 |
510 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
592 |
516 |
$0.00 |